FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2776629303> ?p ?o ?g. }

• W2776629303 endingPage "724" @default.
• W2776629303 startingPage "718" @default.
• W2776629303 abstract "In patients with atrial fibrillation undergoing percutaneous coronary intervention (PCI), the effectiveness and safety of dual compared with triple antithrombotic therapy are a matter of debate, especially when considering the prevention of end points at low incidence, such as myocardial infarction (MI), stent thrombosis, or mortality. This study-level meta-analysis included 4 controlled randomized trials and 6,036 patients with a clinical indication to chronic oral anticoagulation (OAC) after PCI, mainly for atrial fibrillation. Patients receiving dual therapy with a single antiplatelet agent, essentially a P2Y12 inhibitor, plus OAC were compared with those treated with triple therapy (aspirin, a P2Y12 inhibitor, and OAC). The incidence of the following outcomes was evaluated: Thrombolysis In Myocardial Infarction major and minor bleeding, MI, stent thrombosis, stroke, cardiovascular, and all-cause death. Occurrence of Thrombolysis In Myocardial Infarction major bleeding was significantly lower in patients treated with dual therapy: 1.97% versus 3.53% in those on triple therapy (odds ratios 0.55, 95% confidence interval 0.39 to 0.78, p = 0.0007); rates of minor bleeding were also decreased in the former (57% relative reduction). With dual therapy, there was not a statistically significant difference in all-cause and cardiovascular mortality (3.81% vs 4.01%, p = 0.37 and 1.62% vs 2.02%, p = 0.42, respectively). Incidence of MI (3.25% vs 2.78%, p = 0.61), definite stent thrombosis (0.92% vs 0.66%, p = 0.46), and stroke (1.28% vs 1.32%, p = 0.85) was similar in the 2 treatment strategies. In patients with long-term indication to OAC after PCI, compared with triple therapy, dual antithrombotic therapy reduces bleeding, without an excess in thromboembolic and ischemic cardiac events. In patients with atrial fibrillation undergoing percutaneous coronary intervention (PCI), the effectiveness and safety of dual compared with triple antithrombotic therapy are a matter of debate, especially when considering the prevention of end points at low incidence, such as myocardial infarction (MI), stent thrombosis, or mortality. This study-level meta-analysis included 4 controlled randomized trials and 6,036 patients with a clinical indication to chronic oral anticoagulation (OAC) after PCI, mainly for atrial fibrillation. Patients receiving dual therapy with a single antiplatelet agent, essentially a P2Y12 inhibitor, plus OAC were compared with those treated with triple therapy (aspirin, a P2Y12 inhibitor, and OAC). The incidence of the following outcomes was evaluated: Thrombolysis In Myocardial Infarction major and minor bleeding, MI, stent thrombosis, stroke, cardiovascular, and all-cause death. Occurrence of Thrombolysis In Myocardial Infarction major bleeding was significantly lower in patients treated with dual therapy: 1.97% versus 3.53% in those on triple therapy (odds ratios 0.55, 95% confidence interval 0.39 to 0.78, p = 0.0007); rates of minor bleeding were also decreased in the former (57% relative reduction). With dual therapy, there was not a statistically significant difference in all-cause and cardiovascular mortality (3.81% vs 4.01%, p = 0.37 and 1.62% vs 2.02%, p = 0.42, respectively). Incidence of MI (3.25% vs 2.78%, p = 0.61), definite stent thrombosis (0.92% vs 0.66%, p = 0.46), and stroke (1.28% vs 1.32%, p = 0.85) was similar in the 2 treatment strategies. In patients with long-term indication to OAC after PCI, compared with triple therapy, dual antithrombotic therapy reduces bleeding, without an excess in thromboembolic and ischemic cardiac events." @default.
• W2776629303 created "2018-01-05" @default.
• W2776629303 creator A5033373672 @default.
• W2776629303 creator A5055365537 @default.
• W2776629303 date "2018-03-01" @default.
• W2776629303 modified "2023-09-24" @default.
• W2776629303 title "Meta-Analysis Comparing the Safety and Efficacy of Dual Versus Triple Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention" @default.
• W2776629303 cites W1090493624 @default.
• W2776629303 cites W1964435302 @default.
• W2776629303 cites W1975144063 @default.
• W2776629303 cites W1981131402 @default.
• W2776629303 cites W1986215651 @default.
• W2776629303 cites W1991549653 @default.
• W2776629303 cites W2022506351 @default.
• W2776629303 cites W2046051565 @default.
• W2776629303 cites W2063817030 @default.
• W2776629303 cites W2071839802 @default.
• W2776629303 cites W2077033273 @default.
• W2776629303 cites W2080820967 @default.
• W2776629303 cites W2096606175 @default.
• W2776629303 cites W2107328434 @default.
• W2776629303 cites W2108659563 @default.
• W2776629303 cites W2125435699 @default.
• W2776629303 cites W2152623033 @default.
• W2776629303 cites W2159370853 @default.
• W2776629303 cites W2556417520 @default.
• W2776629303 cites W2603452532 @default.
• W2776629303 cites W2620835017 @default.
• W2776629303 cites W2749929702 @default.
• W2776629303 cites W3004050106 @default.
• W2776629303 cites W3183915260 @default.
• W2776629303 doi "https://doi.org/10.1016/j.amjcard.2017.12.014" @default.
• W2776629303 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29373105" @default.
• W2776629303 hasPublicationYear "2018" @default.
• W2776629303 type Work @default.
• W2776629303 sameAs 2776629303 @default.
• W2776629303 citedByCount "40" @default.
• W2776629303 countsByYear W27766293032018 @default.
• W2776629303 countsByYear W27766293032019 @default.
• W2776629303 countsByYear W27766293032020 @default.
• W2776629303 countsByYear W27766293032021 @default.
• W2776629303 countsByYear W27766293032022 @default.
• W2776629303 crossrefType "journal-article" @default.
• W2776629303 hasAuthorship W2776629303A5033373672 @default.
• W2776629303 hasAuthorship W2776629303A5055365537 @default.
• W2776629303 hasConcept C126322002 @default.
• W2776629303 hasConcept C127413603 @default.
• W2776629303 hasConcept C156957248 @default.
• W2776629303 hasConcept C164705383 @default.
• W2776629303 hasConcept C2777015399 @default.
• W2776629303 hasConcept C2777628954 @default.
• W2776629303 hasConcept C2779161974 @default.
• W2776629303 hasConcept C2779581417 @default.
• W2776629303 hasConcept C2780400711 @default.
• W2776629303 hasConcept C2780645631 @default.
• W2776629303 hasConcept C45393284 @default.
• W2776629303 hasConcept C500558357 @default.
• W2776629303 hasConcept C71924100 @default.
• W2776629303 hasConcept C78519656 @default.
• W2776629303 hasConceptScore W2776629303C126322002 @default.
• W2776629303 hasConceptScore W2776629303C127413603 @default.
• W2776629303 hasConceptScore W2776629303C156957248 @default.
• W2776629303 hasConceptScore W2776629303C164705383 @default.
• W2776629303 hasConceptScore W2776629303C2777015399 @default.
• W2776629303 hasConceptScore W2776629303C2777628954 @default.
• W2776629303 hasConceptScore W2776629303C2779161974 @default.
• W2776629303 hasConceptScore W2776629303C2779581417 @default.
• W2776629303 hasConceptScore W2776629303C2780400711 @default.
• W2776629303 hasConceptScore W2776629303C2780645631 @default.
• W2776629303 hasConceptScore W2776629303C45393284 @default.
• W2776629303 hasConceptScore W2776629303C500558357 @default.
• W2776629303 hasConceptScore W2776629303C71924100 @default.
• W2776629303 hasConceptScore W2776629303C78519656 @default.
• W2776629303 hasIssue "6" @default.
• W2776629303 hasLocation W27766293031 @default.
• W2776629303 hasLocation W27766293032 @default.
• W2776629303 hasOpenAccess W2776629303 @default.
• W2776629303 hasPrimaryLocation W27766293031 @default.
• W2776629303 hasRelatedWork W2026729634 @default.
• W2776629303 hasRelatedWork W2034704794 @default.
• W2776629303 hasRelatedWork W2122117983 @default.
• W2776629303 hasRelatedWork W2355614377 @default.
• W2776629303 hasRelatedWork W2375584960 @default.
• W2776629303 hasRelatedWork W2391136434 @default.
• W2776629303 hasRelatedWork W2409008618 @default.
• W2776629303 hasRelatedWork W2775730021 @default.
• W2776629303 hasRelatedWork W3029448752 @default.
• W2776629303 hasRelatedWork W3031425252 @default.
• W2776629303 hasVolume "121" @default.
• W2776629303 isParatext "false" @default.
• W2776629303 isRetracted "false" @default.
• W2776629303 magId "2776629303" @default.
• W2776629303 workType "article" @default.